Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14985098rdf:typepubmed:Citationlld:pubmed
pubmed-article:14985098lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C2936598lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C0034802lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C0109317lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C1705767lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C0003009lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C0752312lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C0598312lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C1370600lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C0040624lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C1366882lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C1150579lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C1333340lld:lifeskim
pubmed-article:14985098lifeskim:mentionsumls-concept:C1705791lld:lifeskim
pubmed-article:14985098pubmed:issue4lld:pubmed
pubmed-article:14985098pubmed:dateCreated2004-2-26lld:pubmed
pubmed-article:14985098pubmed:abstractTextAlthough angiotensin II (Ang II) is known to participate in pancreatic fibrosis, little is known as to the mechanism by which Ang II promotes pancreatic fibrosis. To elucidate the mechanism, we examined the action of Ang II on the proliferation of rat pancreatic stellate cells (PSCs) that play central roles in pancreatic fibrosis. Immunocytochemistry and Western blotting demonstrated that both Ang II type 1 and type 2 receptors were expressed in PSCs. [3H]Thymidine incorporation assay revealed that Ang II enhanced DNA synthesis in PSCs, which was blocked by Ang II type 1 receptor antagonist losartan. Western blotting using anti-phospho-epidermal growth factor (EGF) receptor and anti-phospho-extracellular signal regulated kinase (ERK) antibodies showed that Ang II-activated EGF receptor and ERK. Both EGF receptor kinase inhibitor AG1478 and MEK1 inhibitor PD98059 attenuated ERK activation and DNA synthesis enhanced by Ang II. These results indicate that Ang II stimulates PSC proliferation through EGF receptor transactivation-ERK activation pathway.lld:pubmed
pubmed-article:14985098pubmed:languageenglld:pubmed
pubmed-article:14985098pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:citationSubsetIMlld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14985098pubmed:statusMEDLINElld:pubmed
pubmed-article:14985098pubmed:monthMarlld:pubmed
pubmed-article:14985098pubmed:issn0006-291Xlld:pubmed
pubmed-article:14985098pubmed:authorpubmed-author:KitaHirotoHlld:pubmed
pubmed-article:14985098pubmed:authorpubmed-author:SuganoKentaro...lld:pubmed
pubmed-article:14985098pubmed:authorpubmed-author:YasudaHiroshi...lld:pubmed
pubmed-article:14985098pubmed:authorpubmed-author:TamadaKiichiKlld:pubmed
pubmed-article:14985098pubmed:authorpubmed-author:OhashiAkiraAlld:pubmed
pubmed-article:14985098pubmed:authorpubmed-author:SatohYukihiro...lld:pubmed
pubmed-article:14985098pubmed:authorpubmed-author:OhnishiHirohi...lld:pubmed
pubmed-article:14985098pubmed:authorpubmed-author:MashimaHirosa...lld:pubmed
pubmed-article:14985098pubmed:authorpubmed-author:UedaNamikiNlld:pubmed
pubmed-article:14985098pubmed:authorpubmed-author:HanatsukaKazu...lld:pubmed
pubmed-article:14985098pubmed:authorpubmed-author:HamaKoujiKlld:pubmed
pubmed-article:14985098pubmed:issnTypePrintlld:pubmed
pubmed-article:14985098pubmed:day19lld:pubmed
pubmed-article:14985098pubmed:volume315lld:pubmed
pubmed-article:14985098pubmed:ownerNLMlld:pubmed
pubmed-article:14985098pubmed:authorsCompleteYlld:pubmed
pubmed-article:14985098pubmed:pagination905-11lld:pubmed
pubmed-article:14985098pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:meshHeadingpubmed-meshheading:14985098...lld:pubmed
pubmed-article:14985098pubmed:year2004lld:pubmed
pubmed-article:14985098pubmed:articleTitleAngiotensin II stimulates DNA synthesis of rat pancreatic stellate cells by activating ERK through EGF receptor transactivation.lld:pubmed
pubmed-article:14985098pubmed:affiliationDepartment of Gastroenterology, Jichi Medical School, Tochigi 329-0498, Japan.lld:pubmed
pubmed-article:14985098pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14985098pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14985098lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14985098lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14985098lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14985098lld:pubmed